Indian Scientists Develop This Covid-19 Vaccine To Fight Against Current And Future Variants

Indian Scientists Develop Covid Vaccine To Fight Against Current And Future Variants

By- Shivanshi Srivastava

A promising vaccine candidate to revolutionise fight against COVID is designed by scientists at the Indian Institute of Science.

[{"selector":"#anim-d1275965-073f-47f8-81f5-e7bdaa3a29b6 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.22241199937839%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}]

They have engineered a heat-tolerant vaccine that is effective against all current strains of SARS-CoV-2.

[{"selector":"#anim-1f30812f-06c3-4e89-bd6d-287e08046d54 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-39.06762765838458%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}]

Not just this, it can also combat future variants.

[{"selector":"#anim-4603dd23-2425-4676-9406-5c96fc868132 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.16997573267331%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}]

The vaccine canditate is known a RS2.

[{"selector":"#anim-74d24de6-2b89-4304-a48c-7b1d9b7a9fbf [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.18478251272953%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}]

It combines of two main components of virus's spike protein, ie S2 subunit and Receptor Binding Domain (RBD).

[{"selector":"#anim-8c79d8ed-1913-4703-821b-985f5e353cd2 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.15492948131752%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}]

S2 subunit is less prone to mutations compared to the S1 subunit.

[{"selector":"#anim-a20a8480-362c-4a82-9c72-8d42e540a4a6 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-42.187499904002955%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}]

RBD is recognized for its ability to elicit a robust immune response.

[{"selector":"#anim-ba4c434d-31a1-4df0-a05a-6a0a3f025f77 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-58.203124904002955%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}]

RS2 can be manufactured in large quantities, which is neede for mass vaccination efforts.

[{"selector":"#anim-a9b47bb0-e19e-4978-aea9-b0fbf6527b8b [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-52.08333321955906%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}]